These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 22416392)
1. [Positron emission tomography with 18F-FDG compared with proliferative activity of tumor cells in different subtypes of non-Hodgkin lymphoma]. Tiutin LA; Khodzsibekova MM; Pozharisskiĭ KM; Mukhina MS; Kostenikov NA; Il'in NV Vopr Onkol; 2011; 57(6):748-52. PubMed ID: 22416392 [TBL] [Abstract][Full Text] [Related]
2. Standardised uptake value of 18F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin's lymphoma. Papajík T; Mysliveček M; Sedová Z; Buriánková E; Procházka V; Koranda P; Raida L; Kubová Z; Palová M; Kučerová L; Flodr P; Jarkovský J; Dušek L; Indrák K Eur J Haematol; 2011 Jan; 86(1):32-7. PubMed ID: 20874822 [TBL] [Abstract][Full Text] [Related]
3. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. Schöder H; Noy A; Gönen M; Weng L; Green D; Erdi YE; Larson SM; Yeung HW J Clin Oncol; 2005 Jul; 23(21):4643-51. PubMed ID: 15837966 [TBL] [Abstract][Full Text] [Related]
4. Molecular imaging of proliferation in malignant lymphoma. Buck AK; Bommer M; Stilgenbauer S; Juweid M; Glatting G; Schirrmeister H; Mattfeldt T; Tepsic D; Bunjes D; Mottaghy FM; Krause BJ; Neumaier B; Döhner H; Möller P; Reske SN Cancer Res; 2006 Nov; 66(22):11055-61. PubMed ID: 17108145 [TBL] [Abstract][Full Text] [Related]
5. Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma. Bodet-Milin C; Kraeber-Bodéré F; Moreau P; Campion L; Dupas B; Le Gouill S Haematologica; 2008 Mar; 93(3):471-2. PubMed ID: 18310543 [TBL] [Abstract][Full Text] [Related]
6. [18F-FDG uptake of lymphoma lesions of various histological subtypes]. Ma LF; Fan W Ai Zheng; 2009 Apr; 28(4):425-30. PubMed ID: 19622306 [TBL] [Abstract][Full Text] [Related]
7. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma. Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235 [TBL] [Abstract][Full Text] [Related]
8. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas. Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687 [TBL] [Abstract][Full Text] [Related]
9. SUV on dual-phase FDG PET/CT correlates with the Ki-67 proliferation index in patients with newly diagnosed non-Hodgkin lymphoma. Chang CC; Cho SF; Chen YW; Tu HP; Lin CY; Chang CS Clin Nucl Med; 2012 Aug; 37(8):e189-95. PubMed ID: 22785526 [TBL] [Abstract][Full Text] [Related]
10. Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes. Mosavi F; Wassberg C; Selling J; Molin D; Ahlström H Clin Radiol; 2015 Nov; 70(11):1229-36. PubMed ID: 26208992 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of decreased uptake of 18F-fluorodeoxyglucose in the cerebral cortex of patients with intracranial non-Hodgkin's lymphoma lesions through PET/CT. Zhang Q; Tian T; Wang L; Qiu H; Li D Biomed Pharmacother; 2016 Dec; 84():1331-1336. PubMed ID: 27810790 [TBL] [Abstract][Full Text] [Related]
12. Glucose metabolism correlated with cellular proliferation in diffuse large B-cell lymphoma. Wu X; Pertovaara H; Korkola P; Vornanen M; Eskola H; Kellokumpu-Lehtinen PL Leuk Lymphoma; 2012 Mar; 53(3):400-5. PubMed ID: 21913807 [TBL] [Abstract][Full Text] [Related]
13. Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT. Wang R; Zhu H; Chen Y; Li C; Li F; Shen Z; Tian J; Yu L; Xu B Hematol Oncol; 2014 Sep; 32(3):126-32. PubMed ID: 23996464 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic role of 18F-FDG PET in gastric MALT lymphoma. Ambrosini V; Rubello D; Castellucci P; Nanni C; Farsad M; Zinzani P; Alavi A; Tehranipour N; Al-Nahhas A; Fanti S Nucl Med Rev Cent East Eur; 2006; 9(1):37-40. PubMed ID: 16791802 [TBL] [Abstract][Full Text] [Related]
15. [Correlation of ¹⁸F-FDG uptake with tumor-proliferating antigen Ki-67 expression in aggressive lymphoma]. Liang Y; Wu N; Fang Y; Huang WT; Zhang H; Zheng R; Zhang WJ; Liu Y; Li XM Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):356-60. PubMed ID: 24054012 [TBL] [Abstract][Full Text] [Related]
16. [18F]5-fluoro-2-deoxyuridine-PET for imaging of malignant tumors and for measuring tissue proliferation. Buchmann I; Vogg AT; Glatting G; Schultheiss S; Möller P; Leithäuser F; Schulte M; Gfrörer W; Kotzerke J; Reske SN Cancer Biother Radiopharm; 2003 Jun; 18(3):327-37. PubMed ID: 12954120 [TBL] [Abstract][Full Text] [Related]
17. SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma. Watanabe R; Tomita N; Takeuchi K; Sakata S; Tateishi U; Tanaka M; Fujita H; Inayama Y; Ishigatsubo Y Leuk Lymphoma; 2010 Feb; 51(2):279-83. PubMed ID: 20038236 [TBL] [Abstract][Full Text] [Related]
18. Correlation of fluorodeoxyglucose uptake and tumor-proliferating antigen Ki-67 in lymphomas. Shou Y; Lu J; Chen T; Ma D; Tong L J Cancer Res Ther; 2012; 8(1):96-102. PubMed ID: 22531522 [TBL] [Abstract][Full Text] [Related]
19. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma. Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255 [TBL] [Abstract][Full Text] [Related]
20. Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance. Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Eur J Haematol; 2015 Jul; 95(1):83-9. PubMed ID: 25537478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]